| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: A validation study
|
Barde, François
|
|
|
64 |
C |
p.
|
article
|
| 2 |
A meta-analysis of the association between the ATIC 347 C/G polymorphism and methotrexate responsiveness and toxicity in rheumatoid arthritis
|
Lee, Young Ho
|
|
|
64 |
C |
p.
|
article
|
| 3 |
Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register
|
Molina-Collada, Juan
|
|
|
64 |
C |
p.
|
article
|
| 4 |
Cardiovascular safety of zoledronic acid in the treatment of primary osteoporosis: A meta-analysis and systematic review
|
Liu, ShuangHua
|
|
|
64 |
C |
p.
|
article
|
| 5 |
Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort
|
Ahn, Sung Soo
|
|
|
64 |
C |
p.
|
article
|
| 6 |
Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases
|
Lyne, Suellen A.
|
|
|
64 |
C |
p.
|
article
|
| 7 |
Continuing versus tapering low-dose glucocorticoids in patients with rheumatoid arthritis and systemic lupus erythematosus in states of low disease activity or remission: A systematic review and meta-analysis of randomised trials
|
Palmowski, Andriko
|
|
|
64 |
C |
p.
|
article
|
| 8 |
Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working group
|
Balay-Dustrude, Erin
|
|
|
64 |
C |
p.
|
article
|
| 9 |
Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study
|
Muratore, Francesco
|
|
|
64 |
C |
p.
|
article
|
| 10 |
Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease
|
Juge, Pierre-Antoine
|
|
|
64 |
C |
p.
|
article
|
| 11 |
Evaluation of a measure of end-stage knee osteoarthritis compared to total knee replacement: An observational study using multicohort data
|
Salis, Zubeyir
|
|
|
64 |
C |
p.
|
article
|
| 12 |
Exploring the complexities of pain phenotypes: OMERACT 2023 chronic pain working group workshop
|
Pickles, Tim
|
|
|
64 |
C |
p.
|
article
|
| 13 |
Giant cell arteritis associated with scalp, tongue or lip necrosis: A French multicenter case control study
|
Chehem Daoud Chehem, Ferida
|
|
|
64 |
C |
p.
|
article
|
| 14 |
IgG4-related uveitis. A French cohort and literature review
|
Stuchfield-Denby, Emily
|
|
|
64 |
C |
p.
|
article
|
| 15 |
Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer
|
McCarter, Kaitlin R.
|
|
|
64 |
C |
p.
|
article
|
| 16 |
Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study
|
Simon, Teresa A.
|
|
|
64 |
C |
p.
|
article
|
| 17 |
Interstitial lung disease phenotype in mixed, differentiated, or overlapping, connective tissue diseases: Comment on the article by Boleto et al.
|
Chevalier, Kevin
|
|
|
64 |
C |
p.
|
article
|
| 18 |
Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world data analysis
|
van Ouwerkerk, L.
|
|
|
64 |
C |
p.
|
article
|
| 19 |
Letter to the editor regarding “The phenotype of mixed connective tissue disease patients having associated interstitial lung disease”
|
Shih, Po-Cheng
|
|
|
64 |
C |
p.
|
article
|
| 20 |
Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study
|
Simon, Teresa A
|
|
|
64 |
C |
p.
|
article
|
| 21 |
Multimorbidity phenotypes in ankylosing spondylitis and their association with disease activity and functional impairment: Data from the prospective study of outcomes in ankylosing spondylitis cohort
|
Karmacharya, Paras
|
|
|
64 |
C |
p.
|
article
|
| 22 |
Obesity is an independent risk factor for cancer development following diagnosis of dermatomyositis
|
Allenzara, Astia
|
|
|
64 |
C |
p.
|
article
|
| 23 |
Pathogenesis, assessment, and management of bone loss in axial spondyloarthritis
|
Nakamura, Akihiro
|
|
|
64 |
C |
p.
|
article
|
| 24 |
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set
|
Benavent, Diego
|
|
|
64 |
C |
p.
|
article
|
| 25 |
Persistence of Janus-kinase (JAK) inhibitors in rheumatoid arthritis: Australia wide study
|
Scheepers, Lieke
|
|
|
64 |
C |
p.
|
article
|
| 26 |
Response to comments on “The phenotype of mixed connective tissue disease patients having associated interstitial lung disease” by Chevalier K et al. and Shih PC
|
Boleto, Gonçalo
|
|
|
64 |
C |
p.
|
article
|
| 27 |
Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group
|
Saygin, D
|
|
|
64 |
C |
p.
|
article
|
| 28 |
Rheumatoid interstitial lung disease in Canterbury, Aotearoa New Zealand – A retrospective cohort study
|
Farquhar, Hamish J.
|
|
|
64 |
C |
p.
|
article
|
| 29 |
Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis
|
He, Xing
|
|
|
64 |
C |
p.
|
article
|
| 30 |
Systematic calibration reduces sources of variability for the preliminary OMERACT juvenile idiopathic arthritis MRI- sacroiliac joint score (OMERACT JAMRIS-SIJ)
|
Maksymowych, Walter P.
|
|
|
64 |
C |
p.
|
article
|
Journal description